About Corgenix
Corgenix is a company based in Broomfield (United States) founded in 1990 was acquired by Orgentec Diagnostika in August 2014.. The company has 24 employees as of December 31, 2022. Corgenix offers products and services including M-inSight® and Diagnostic Solutions. Corgenix operates in a competitive market with competitors including Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Frontage Laboratories, among others.
- Headquarter Broomfield, United States
- Employees 24 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
HHS
& 2 more
-
Employee Count
24
as on Dec 31, 2022
-
Acquired by
Orgentec Diagnostika
(Aug 28, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Corgenix
Corgenix offers a comprehensive portfolio of products and services, including M-inSight® and Diagnostic Solutions. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Test for monitoring multiple myeloma patients in clinical settings
Services for clinical studies and trial management support
Funding Insights of Corgenix
- Total Funding Total Funding
- Total Rounds 5
- Last Round Last Round
-
First Round
First Round
(01 Sep 2007)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2014 | Amount | Grant - Corgenix | Valuation |
investors |
|
| Jul, 2010 | Amount | Post-IPO - Corgenix | Valuation |
investors |
|
| Apr, 2010 | Amount | Grant - Corgenix | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Corgenix
Corgenix has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include HHS, European Union and Orgentec Diagnostika. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Diagnostics tools for Autoimmune and Infectious Diseases
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Corgenix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Corgenix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Corgenix Comparisons
Competitors of Corgenix
Corgenix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Frontage Laboratories, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of drug discovery and preclinical development services
|
|
| domain | founded_year | HQ Location |
Data analysis and statistical solutions are provided for life sciences.
|
|
| domain | founded_year | HQ Location |
Provider of laboratory tests for physicians
|
|
| domain | founded_year | HQ Location |
Provider of clinical research, development, and commercialization services for life sciences
|
|
| domain | founded_year | HQ Location |
Early drug development services are provided for pharma firms.
|
|
| domain | founded_year | HQ Location |
Genetic and clinical data are integrated for precision cardiac medicines.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Corgenix
Frequently Asked Questions about Corgenix
When was Corgenix founded?
Corgenix was founded in 1990 and raised its 1st funding round 17 years after it was founded.
Where is Corgenix located?
Corgenix is headquartered in Broomfield, United States. It is registered at Broomfield, Colorado, United States.
Who is the current CEO of Corgenix?
Werner Hofacher is the current CEO of Corgenix.
How many employees does Corgenix have?
As of Dec 31, 2022, the latest employee count at Corgenix is 24.
What does Corgenix do?
Founded in 1990, Corgenix is headquartered in Broomfield, United States. Focus is placed on the healthcare sector, where in vitro diagnostic tests for vascular diseases are created and distributed. Operations involve research, manufacturing, and commercialization of these medical products to support clinical applications. Leadership is provided by CEO Werner Hofacher, with activities centered in the United States market.
Who are the top competitors of Corgenix?
Corgenix's top competitors include LabCorp, Charles River Laboratories and Cytel.
What products or services does Corgenix offer?
Corgenix offers M-inSight® and Diagnostic Solutions.
Who are Corgenix's investors?
Corgenix has 3 investors. Key investors include HHS, European Union, and Orgentec Diagnostika.